Trials / Completed
CompletedNCT01253824
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Pharmacodynamics of NPC-01( 1mg Norethisterone and 0.02mg Ethinyl Estradiol) and IKH-01( 1mg Norethisterone and 0.035mg Ethinyl Estradiol); Effect of NPC-01 and IKH-01 on Serum Concentrations of Estradiol, Progesterone, FSH and LH.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the serum levels of estradiol, progesterone, FSH and LH in NPC-01 or IKH-01 one treatment cycle with those in before and after administration cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-01 | NPC-01 contains 1mg norethisterone and 0.02mg ethinyl estradiol |
| DRUG | IKH-01 | IKH-01 contains 1mg norethisterone and 0.35mg ethinyl estradiol |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-12-03
- Last updated
- 2025-03-06
- Results posted
- 2014-06-17
Source: ClinicalTrials.gov record NCT01253824. Inclusion in this directory is not an endorsement.